0001209191-20-059256.txt : 20201118 0001209191-20-059256.hdr.sgml : 20201118 20201118193124 ACCESSION NUMBER: 0001209191-20-059256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sherman Matthew L CENTRAL INDEX KEY: 0001325710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 201326658 MAIL ADDRESS: STREET 1: C/O RADIUS HEALTH, INC. STREET 2: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-16 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001325710 Sherman Matthew L C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451 0 1 0 0 EVP & Chief Medical Officer Common Stock 2020-11-16 4 M 0 2697 34.43 A 37211 D Stock Option (Right to buy) 34.43 2020-11-16 4 M 0 2697 0.00 D 2029-10-14 Common Stock 2697 147303 D Includes 386 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 14, 2020. This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the options shall vest on October 1, 2020, and the remaining options shall vest in equal monthly installments over the following three years, subject to continued service through such dates. /s/ Jeffrey Held, Attorney-in-Fact 2020-11-18